ALNY vs ASYS · P/E 76, rev $1.29B vs rev $61.8M
Alnylam Pharmaceuticals Inc (ALNY) versus Amtech Systems Inc (ASYS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Amtech Systems Inc (ASYS) is a semiconductor equipment & materials company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported ASYS revenue for 2026-06-30 was $61.8M. Net income was $2.9M. Revenue was up 56.8% from 2026-03-31 to 2026-06-30. ASYS currently screens at market cap $64.1M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ASYS currently screens at market cap $64.1M.
Not investment advice. Open the ALNY and ASYS stock pages for the full models.
Not investment advice.